Excelsior Research Pvt Ltd

Influenza Vaccine Market Size is Likely to be Valued at USD 4.52 Billion by 2025 Expanding with a CAGR of 12.0% over the Forecast Period

Excel Report has announced a new report titled “Influenza Vaccine Market Size is Likely to be Valued at USD 4.52 Billion by 2025 Expanding with a CAGR of 12.0% over the Forecast Period” to their offerings.


Beverly Hills, CA -- (ReleaseWire) -- 08/24/2018 --Excel Report has released its latest research-based report entitled “Global Influenza Vaccine Market" Market. As of 2017, the Influenza Vaccine market size was valued at USD 4.52 billion and is projected to grow at a CAGR of 12.0%. As the world moves towards an aging population, people’s susceptibility to influenza increases, raising demand for flu vaccines. Also improving healthcare systems, growing flu awareness and high birth rates in developing countries will fuel demand for existing and new influenza vaccines from 2017. The influenza vaccination industry thus holds great potential for progress and high sales.

Read Comprehensive Overview of Report @ http://www.excellreports.com/product/life-sciences/influenza-vaccine-market/

Influenza vaccine market is expected to flourish rapidly in the near future. The key factor attributing to the market growth is the need for development of new version of influenza vaccine owing to the frequently changing influenza virus. Moreover, escalating demand of pediatrics influenza vaccines as well as high demand from emerging markets is also expected to fuel market growth during the forecast period.

The influenza vaccines market is majorly dominated by only 4 major pharmaceutical companies dominating the industry: Sanofi Pasteur, Seqirus, GSK and AstraZeneca. Sanofi held the largest share in the market with its bestselling influenza vaccine, Vaxigrip/Fluzone HD/Fluzone. It accounted for maximum share in 2017 and is anticipated to maintain its dominance throughout the forecast period.

Get Free Sample Copy of this Report @ http://bit.ly/RequestForSampleGlobalInfluenzaVaccineMarket

Table Of Contents:

1. Market Introduction

1.1 Introduction

1.2 Scope of Study

1.2.1 Research Objective

1.3 Currency & Pricing

1.4 Limitations

1.5 Assumptions

2. Executive Summary

2.1 Global Influenza Vaccine Market Projection, 2018 – 2025

2.2 Global Influenza Vaccine Market Growth, By Regions

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.4.1 Bottom-up Approach

3.4.2 Top-down Approach

3.4.3 Market Breakdown and Data Triangulation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 PEST Analysis

4.3.1 Political

4.3.2 Economical

4.3.3 Social

4.3.4 Technological

4.4 Porters Five Forces Analysis

4.5 SWOT Analysis

4.5.1 Strengths

4.5.2 Weaknesses

4.5.3 Opportunities

4.5.4 Threats

5. Global Influenza Vaccine Market, By Product

5.1 Product Overview

5.2 Vaxigrip/Fluzone HD/Fluzone

5.3 Afluria/Fluvirin/Fluad/Flucelvax/Aggripal

5.4 Fluarix/FluLaval

5.5 FluMist/Fluenz

Ask for Discount @ http://bit.ly/InquireForDiscountInfluenzaVaccineMarket

About Excell Reports
Excell reports is one of the leading distributors of Market Intelligence reports produced by premium publishers. Being a one stop solution for research requirements, our Market Intelligence reports help our clients to keep abreast of thousands of industries all-round the globe. A better understanding of the predicted market conditions, a clear picture of supply and source industries allows our clients to closely monitor competitor activities. Our large database of more than 50,000 quality driven reports from over 40+ leading publisher ensures that your market research